Key Metrics of Polyrizon Ltd.
Revenue—FY 2023
Operating income−$635K▲ 29.1% YoY
Net profit−$600K▲ 23.0% YoY
Shareholders' equity−$191K
Market cap$22.3MPLRZ · $9.20
Competitors10identified
About Polyrizon Ltd.
Sectors
Company details
- Founded
- 2024
- Listed
- Nasdaq: PLRZ (since 2024)
Operational Areas of Polyrizon Ltd.
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal namePolyrizon Ltd.
TickerPLRZ
ExchangeNasdaq
CountryIsrael
SEC CIK0001893645
Listed since2024
IndustryMedical/Dental Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
PLRZ · Nasdaq · SEC CIK 0001893645
Last price · 23 Oct 2026
$9.20
+0.55%
Market cap$22.3M
P/E0.0On FY 2023 diluted EPS
Volume7,020
SectorHealth CareMedical/Dental Instruments
Country · IPOIsraelListed 2024
PLRZ share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Polyrizon Ltd.
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.